Compositions comprising modulators of ribonucleoprotein granule formation and dissolution and methods of use thereof
AssigneeUniversity of Virginia Patent Foundation
InventorsKu-Lung Hsu, Anthony Michael Ciancone
Life of this patent
Estimating the term…
Abstract
Provided are sulfonyl triazole compounds as well as compositions thereof and methods for using the same for modulating the formation of ribonucleoprotein granules (RNPGs), treating symptoms of diseases or infections in subjects including but not limited to viral infections, cancers and/or tumors, and/or neurological diseases. In some embodiments, the sulfonyl triazole compounds have the structure of Formula (I) as defined herein.
Claims21
A method for modulating the formation of ribonucleoprotein granules (RNPGs), the method comprising contacting a sample comprising a protein with a sulfonyl triazole compound, thereby covalently modifying the protein.
A method for treating a symptom of a disease or infection in a subject in need thereof, wherein the method comprises administering to the subject an effective amount of a sulfonyl triazole compound of Formula (I):
- wherein:
- X1 and X2 are each CH or N, subject to the proviso that when X1 is CH, X2 is N and when X1 is N, X2 is CH;
- R1 is selected from alkyl, cycloalkyl, aralkyl, aryl, and substituted aryl;
- and
- R2 is selected from alkyl, substituted alkyl, aralkyl, substituted aralkyl, aryl, and substituted aryl, wherein said administrating modulates the formation of pathological ribonucleoprotein granules (RNPGs).
A sulfonyl triazole compound, wherein said sulfonyl triazole compound is selected from the group consisting of:
A composition for use in treating a symptom associated with a viral infection, cancer, or a neurological disease, wherein the composition comprises a compound of Formula (I):
- wherein:
- X1 and X2 are each CH or N, subject to the proviso that when X1 is CH, X2 is N and when X1 is N, X2 is CH;
- R1 is selected from alkyl, cycloalkyl, aralkyl, aryl, and substituted aryl;
- and
- R2 is selected from alkyl, substituted alkyl, aralkyl, substituted aralkyl, aryl, and substituted aryl, wherein said administrating modulates the formation of pathological ribonucleoprotein granules (RNPGs).
Dependencies are inferred from the claim text.